ULCERATIVE COLITIS CHRONIC SEVERE

Clinical trials for ULCERATIVE COLITIS CHRONIC SEVERE explained in plain language.

Never miss a new study

Get alerted when new ULCERATIVE COLITIS CHRONIC SEVERE trials appear

Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC SEVERE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat colitis flares

Disease control Recruiting now

This study is testing a new oral drug called BRS201 for adults experiencing a severe flare-up of ulcerative colitis who haven't gotten better with steroid treatment. Over 12 weeks, participants will take the study drug for 4 weeks and have several clinic visits for check-ups and …

Matched conditions: ULCERATIVE COLITIS CHRONIC SEVERE

Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

ULCERATIVE COLITIS CHRONIC SEVERE

Get alerted when new ULCERATIVE COLITIS CHRONIC SEVERE trials appear

New hope for Tough-to-Treat colitis flares